Screening study of lung US (LUS) vs HRCT in 73 RA pts (DAS28 3.47) Chest HRCT identified ILD in 29%. LUS identified ILD
Screening study of lung US (LUS) vs HRCT in 73 RA pts (DAS28 3.47) Chest HRCT identified ILD in 29%. […]
Screening study of lung US (LUS) vs HRCT in 73 RA pts (DAS28 3.47) Chest HRCT identified ILD in 29%. […]
RT @ericdeinMD #RNL26 Arthroplasty risks in RMD AxSpA – Respiratory complications (OR 1.7), PNA (2.2) SLE – complicat https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RT @ericdeinMD #RNL26 Inflammatory arthritis pts getting TKA: – increased risk of RBC transfusion (OR 1.39), infectio https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
Achieving early clinical response was associated with cumulative benefits on disease impact up to 2 years in patients with active
RT @RichardPAConway UIP pattern RA-ILD is where the big problem is. We are less good at treating this. Perhaps the
RNL 26 Report: Spondyloarthritis Audrey Gibson, PA-C, reports from RheumNow Live 2026 in Dallas, Texas, about lectures https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon,
Obesity, Surgery, and Optimizing Patient Care Rheumatologic care requires a multidisciplinary approach and collaborati https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 02/16/2026 – 13:00
The vasculitis session at #RNL26 was a fantastic update on inflamed blood vessels, large and small, by two experts in
Disease Modification, Disparities and the Next Therapeutic Frontier in Gout gibsonab@hotmail.com Mon, 02/16/2026 – 10:36
RT @RichardPAConway Comparative survival in incident RA-ILD 1955-1995 vs 1999-2014. We are getting better, althoug need https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 02/16/2026
RT @ericdeinMD #RNL26 @RheumNow Uzma Haque GLP1 on pts with  SLE and diabetes Retrospective study – major improvement https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RT @gibson_rheumPAC Helicobacter pylori Update: H. Pylori remains the most common chronic bacterial infection worldwide, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 02/15/2026 –
RT @gibson_rheumPAC Gout flares are not benign. Recent flares double MI/stroke risk and markedly increase CV mortality? https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun,
RT @gibson_rheumPAC Baseline serum urate >8–9 mg/dL strongly predicts worse flares, hospitalizations, and join https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 02/15/2026 – 14:00
“The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he
RT @gibson_rheumPAC Arthur Kavanaugh’s RheumNow 2026: Why Do Plain X-Rays in Psoriatic Arthritis? Thought-provoking s https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 02/15/2026 –
RT @Gibson_RheumPAC A good reminder: PsA treatment should be domain-based. Skin, peripheral joints, axial disease, and https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 02/15/2026
RT @gibson_RheumPAC Axial PsA remains an area of active investigation. IL-17 inhibitors show consistent benefit, while https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Sun, 02/15/2026
RT @ericdeinMD #RNL26 GLP on Knee OA STEP 9 Trial – 68 wk Mean WOMAC improved by 41.7 pts, compared
RT @ericdeinMD #RNL26 Haque Effect of GLP1 on Pts with RA Retrospective study Significant reduction is RA disease activi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RT @ericdeinMD #RNL26 Haque TOGETHER-PsA -P3B study of IXE v IXE + Tirzepatide BMI >27 + 1 wt related co-morbid
RT @richardPAconway We have improved RA mortality in many areas but respiratory (mainly ILD) and infectious issues remai https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
RT @richardPAConway AUC of various published screening strategies for RA-ILD. We often say 0.80 is an acceptable cut off https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
RT @RichardPAConway Odds ratios for ILD in early RA from SAIL-RA study. Again disease activity stands out. #RNL26 https https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Comorbidity & Health Management tammytilley@gm… Sat, 02/14/2026 – 09:35 Body Slide deck from the APP Campaign, “Comorbidity and Health Management”
RNL 26 Report: Rheumatoid Arthritis tammytilley@gm… Sat, 02/14/2026 – 08:49 Rheumatoid Arthritis Education/ACR/EULAR Cardio/Pulmonary Outcomes Audrey Gibson, PA-C, reports from
RT @Gibson_RheumPAC Drug-induced SCLE remains an important mimic in biologic-treated patients. Compared with idiopathi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 02/13/2026 – 20:00